Cargando…
Therapeutic effects of faricimab on aflibercept-refractory age-related macular degeneration
Though vascular endothelial growth factors (VEGF) and other proangiogenic factors, such as angiopoietins (Ang), may be involved in the development of neovascular age-related macular degeneration (nvAMD), only drugs that inhibit the VEGF family are available for the treatment. The newly approved anti...
Autores principales: | Tamiya, Ryosuke, Hata, Masayuki, Tanaka, Asako, Tsuchikawa, Memiri, Ueda-Arakawa, Naoko, Tamura, Hiroshi, Miyata, Manabu, Takahashi, Ayako, Kido, Ai, Muraoka, Yuki, Miyake, Masahiro, Ooto, Sotaro, Tsujikawa, Akitaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689783/ https://www.ncbi.nlm.nih.gov/pubmed/38036627 http://dx.doi.org/10.1038/s41598-023-48190-6 |
Ejemplares similares
-
Four-Year Outcome of Aflibercept for Neovascular Age-Related Macular Degeneration and polypoidal choroidal vasculopathy
por: Nishikawa, Keiichi, et al.
Publicado: (2019) -
Effects of Intravitreous Aflibercept Injection in Pachychoroid Neovasculopathy: Comparison with Typical Neovascular Age-Related Macular Degeneration
por: Elfandi, Sufian, et al.
Publicado: (2021) -
Influence of vitreomacular interface score on treatment outcomes of anti-VEGF therapy for neovascular age-related macular degeneration
por: Miyata, Manabu, et al.
Publicado: (2021) -
Natural Course of Pachychoroid Pigment Epitheliopathy
por: Yagi, Mariko, et al.
Publicado: (2022) -
Effectiveness of Reduced-fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Propensity Score Analysis
por: Aisu, Nao, et al.
Publicado: (2022)